submit news    HOME | FEEDBACK  


- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials


- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events

Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here


MagForce Nanotechnologies
MagForce Nanotechnologies is the world's leading company in the area of nanotechnology-based cancer therapy. Its patented therapy allows the targeted destruction of tumors using magnetic nanoparticles. MagForce's nanotechnology represents a revolutionary approach to the future successful treatment of solid cancers.

3/11/2011 8:54:45 AM | Industry | 0 comments
Nanostart Subsidiary MagForce Nanotechnologies AG Hires Key Members of Sales and Marketing Team
Experienced commercial team prepared to launch NanoTherm therapy for the treatment of brain tumors
11/17/2010 5:05:34 PM | Industry | 0 comments
Nanostart Subsidiary MagForce Receives Renowned Business Award
Nanostart subsidiary MagForce Nanotechnologies AG a leader in the area of nanotechnology-based cancer treatment, has been selected as the 2010 recipient of the STEP award in the category “product/technology”.
9/21/2010 9:13:46 AM | Nanoparticles | 0 comments
MagForce Nanotechnologies AG Announces Publication of Clinical Data Using Nanoparticles for the Treatment of Recurrent Glioblastoma Multiforme
MagForce Nanotechnologies AG announced today the publication of clinical data from a clinical study examining the safety and efficacy of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy in patients with recurrent glioblastoma multiforme.
6/30/2010 12:41:26 AM | Bio/Medicine | 0 comments
MagForce Nanotechnologies AG Receives European Regulatory Approval for Its Nano-Cancer Therapy
The official notice of regulatory approval signifies that the authorized testing centers in Germany responsible for conformity evaluation of medical devices have completed their examination of the application submitted for market approval of Nano-Cancer therapy and that the approved medical devices fulfill all requirements with regard to quality, safety and medical efficacy.
5/4/2010 6:20:56 PM | Industry | 0 comments
MagForce Nanotechnologies AG Secures Financing up to EUR 20 Million Through an Equity Line
Provides additional resources for the European market launch of Nano-Cancer therapy.
12/1/2009 12:26:40 AM | Bio/Medicine | 0 comments
MagForce Nanotechnologies AG Applies for European Regulatory Approval of Its Nano-Cancer Therapy
Following successful completion of this conformity assessment procedure and EC type testing of the magnetic field applicator, MagForce will be able to apply the CE European conformity marking and to market its Nano-Cancer therapy throughout the European Union.
11/4/2009 8:28:54 AM | Bio/Medicine | 0 comments
Nanostart Majority-Owned MagForce Announces Successful Completion of Final Clinical Trials For Nano-Cancer Therapy
Therapy shown to be highly effective, with minimal side effects
9/22/2009 11:40:15 PM | Bio/Medicine | 0 comments
MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study
MagForce Nanotechnologies AG has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-Cancer therapy.
6/14/2005 7:59:37 PM | Industry | 0 comments
Frost & Sullivan Laurels for MagForce Nanotechnologies' Breakthrough Nano-Based Cancer Therapeutic
MagForce's patented absorption technology enables tumour cells to absorb these nanoparticles selectively. The nanoparticles, in turn support the selective heating of the tumour tissue on a cellular level, thereby destroying the tumour cells.

« Back To List »

- submit company
- submit news
- submit events
- advertise here

- More Events

Copyright © 2017 | Privacy Policy |